Metric Snapshot
- Latest value
- -53620%
- Coverage range
- 30 Jun 2017 - 30 Sep 2023
- Fact rows
- 26
Shareable Research Card
IBIO - iBio, Inc. Operating Margin
This metric view shows IBIO - iBio, Inc. operating margin history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q3 2023
- Latest reported value
- -53620%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Financial Metric Page
iBio, Inc.: Operating Margin
Latest period: Q3 2023. Period end: 30 Sep 2023. Units: %. Frequency: quarterly and annual.
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
What This Metric Tells You
- Shows the reported level of operating margin over 30 Jun 2017 - 30 Sep 2023.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 26 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Global Warming Solutions, Inc. (["gwso"]) | 99905400% | Quarter - 30 Sep 2022 | Open Global Warming Solutions, Inc. Operating Margin |
| 2 | NAMI Corp. ([]) | 1080289% | Quarter - 31 Mar 2021 | Open NAMI Corp. Operating Margin |
| 3 | PharmaCyte Biotech, Inc. (["pmcb"]) | 396584% | Quarter - 31 Jan 2014 | Open PharmaCyte Biotech, Inc. Operating Margin |
| 4 | ALR Technologies SG Ltd. (["alrtf"]) | 180380% | Year - 31 Dec 2022 | Open ALR Technologies SG Ltd. Operating Margin |
| 5 | MUSTANG BIO, INC. (["mbio"]) | 83624% | Quarter - 30 Sep 2019 | Open MUSTANG BIO, INC. Operating Margin |
| 6 | DOMINION ENERGY SOUTH CAROLINA, INC. ([]) | 63100% | Quarter - 31 Dec 2020 | Open DOMINION ENERGY SOUTH CAROLINA, INC. Operating Margin |
Metric Details
- Metric
- Operating Margin (OperatingMargin)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 30 Jun 2017 - 30 Sep 2023
- Facts on this page
- 26
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
iBio, Inc. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q3 2023 | -53620% | -51836% | -2906% | 01 Jul 2023 | 30 Sep 2023 |
| Q4 2022 | -1969% | +202% | +9.3% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -1784% | -346% | -24% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -1576% | -264% | -20% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -1208% | -388% | -47% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -2171% | -1251% | -136% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -1438% | -558% | -63% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -1312% | -457% | -53% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -820% | +332% | +29% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -921% | -70% | -8.3% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | -880% | -126% | -17% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | -855% | -73% | -9.3% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | -1152% | +41% | +3.5% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | -851% | +930% | +52% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | -754% | +3283% | +81% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | -782% | +2422% | +76% | 01 Apr 2019 | 30 Jun 2019 |
| Q1 2019 | -1193% | 01 Jan 2019 | 31 Mar 2019 | ||
| Q4 2018 | -1781% | 01 Oct 2018 | 31 Dec 2018 | ||
| Q3 2018 | -4037% | 01 Jul 2018 | 30 Sep 2018 | ||
| Q2 2018 | -3204% | 01 Apr 2018 | 30 Jun 2018 |
iBio, Inc. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2022 | -1576% | -264% | -20% | 01 Jul 2021 | 30 Jun 2022 |
| 2021 | -1312% | -457% | -53% | 01 Jul 2020 | 30 Jun 2021 |
| 2020 | -855% | -73% | -9.3% | 01 Jul 2019 | 30 Jun 2020 |
| 2019 | -782% | +2422% | +76% | 01 Jul 2018 | 30 Jun 2019 |
| 2018 | -3204% | +419% | +12% | 01 Jul 2017 | 30 Jun 2018 |
| 2017 | -3623% | 01 Jul 2016 | 30 Jun 2017 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.